Circio News and Activities

Circio is a company listed under the stock ticker TA5 (NO).

View the org chart displaying its 11 main executives

Most searched biographies at Circio

• Erik Wiklund, Chief Executive Officer
• Robert Burns, Board Member
• Damian Marron, Chairman of the Board

Create your alert
to follow the executive moves at Circio.

Circio has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Circio

• Circio completes transformational fundraising of NOK 300 million to strengthen its position as the global leader in circular RNA-based gene expression systems - Circio
• Press releases - Circio
• Circio presents groundbreaking in vivo data showing up to 50-fold enhanced circVec-AAV gene expression in eye - Circio
• Press releases - Circio
• Circio presents data that further strengthens and broadens its circVec circular RNA expression platform - Circio
• Press releases - Circio
• Circio presents circVec circular RNA in vivo expression proof-of-concept data at ESGCT 2024 annual meeting - Circio
• Press releases - Circio
• Press releases - Circio
• Press releases - Circio
• View more press releases Close

Social media about Circio

• Circio on Wikipedia, Google News & Yahoo Finance
• Circio on LinkedIn, X (Twitter) & YouTube